Temasek Holdings (Private) LTD Ab Cellera Biologics Inc. Transaction History

Temasek Holdings (Private) LTD

  • $24.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 15, 2023
BUY
$5.72 - $10.65 $1.61 Million - $3 Million
281,729 New
281,729 $3 Million
Q2 2022

Aug 15, 2022
BUY
$5.72 - $10.65 $1.61 Million - $3 Million
281,729 New
281,729 $3 Million
Q4 2021

Feb 14, 2022
SELL
$12.99 - $17.73 $3.21 Million - $4.38 Million
-246,907 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$14.85 - $21.34 $150,118 - $215,726
10,109 Added 4.27%
246,907 $4.95 Million
Q2 2021

Aug 16, 2021
BUY
$20.19 - $34.17 $4.78 Million - $8.09 Million
236,798 New
236,798 $5.21 Million

Others Institutions Holding ABCL

# of Institutions
154
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $864M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Temasek Holdings (Private) LTD Portfolio

Follow Temasek Holdings (Private) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email